On a per-share basis, the Boston-based company said it had profit of $3.50. Earnings, adjusted for one-time gains and costs, were $3.98 per share. The results did not meet Wall Street expectations.

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report), with ...

In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Alto Neuroscience, Inc. (ANRO – Research Report), with ...

U.S. stock futures rose on Monday after Friday’s sharp fall as investors digested the tariff updates and earnings reports.

Axcelis Technologies, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2024. For ...

Heidrick & Struggles International, Inc. ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global leadership advisory and on-demand talent solutions, today announced it will ...

This article is a text version of a Wall Street Journal newsletter published earlier today.

The S&P 500 Index ($SPX) (SPY) today is up +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.25%, and the Nasdaq ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

The focus of Wall Street investors in the week ahead will be primarily on expected reciprocal trade tariffs by US President ...

Stocks are marking daily gains, but it's nothing to write home about as investors await an update on tariffs while readying ...